Atlas Trials

Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension

Clinical trial NCT07297797 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07297797
Sponsor
Fujian Shengdi Pharmaceutical Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Mild to Moderate Hypertension
Start date
2026-01-14
Primary completion
2026-12-01
Enrollment
238

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.